PL2264055T3 - Klonowanie, ekspresja w drożdżach i aktywność biologiczna regionu wydłużenia podjednostki alfa globuliny sojowej 7S zaangażowanej w homeostazę cholesterolu w komórkach HepG2 - Google Patents

Klonowanie, ekspresja w drożdżach i aktywność biologiczna regionu wydłużenia podjednostki alfa globuliny sojowej 7S zaangażowanej w homeostazę cholesterolu w komórkach HepG2

Info

Publication number
PL2264055T3
PL2264055T3 PL09162939T PL09162939T PL2264055T3 PL 2264055 T3 PL2264055 T3 PL 2264055T3 PL 09162939 T PL09162939 T PL 09162939T PL 09162939 T PL09162939 T PL 09162939T PL 2264055 T3 PL2264055 T3 PL 2264055T3
Authority
PL
Poland
Prior art keywords
hep
alfa
globulin
cloning
soybean
Prior art date
Application number
PL09162939T
Other languages
English (en)
Inventor
Paolo Morazzoni
Antonella Riva
Cesare Ponzone
Davide Berlanda
Marcello Duranti
Alessandro Consonni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PL2264055T3 publication Critical patent/PL2264055T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/43—Sweetening agents, e.g. thaumatin, monellin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/84—Pichia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL09162939T 2009-06-17 2009-06-17 Klonowanie, ekspresja w drożdżach i aktywność biologiczna regionu wydłużenia podjednostki alfa globuliny sojowej 7S zaangażowanej w homeostazę cholesterolu w komórkach HepG2 PL2264055T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09162939.4A EP2264055B1 (en) 2009-06-17 2009-06-17 Cloning, yeast expression, purification and biological activity of the extension region of the soybean 7S globulin alfa' subunit involved in Hep G2 cell cholesterol homeostasis

Publications (1)

Publication Number Publication Date
PL2264055T3 true PL2264055T3 (pl) 2014-09-30

Family

ID=41258337

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09162939T PL2264055T3 (pl) 2009-06-17 2009-06-17 Klonowanie, ekspresja w drożdżach i aktywność biologiczna regionu wydłużenia podjednostki alfa globuliny sojowej 7S zaangażowanej w homeostazę cholesterolu w komórkach HepG2

Country Status (20)

Country Link
US (1) US8569455B2 (pl)
EP (2) EP2264055B1 (pl)
JP (1) JP5778138B2 (pl)
KR (1) KR101689640B1 (pl)
CN (1) CN102753571B (pl)
AU (1) AU2010262061B2 (pl)
BR (1) BRPI1010686A2 (pl)
CA (1) CA2765737C (pl)
CL (1) CL2011003159A1 (pl)
DK (1) DK2264055T3 (pl)
ES (1) ES2460898T3 (pl)
HR (1) HRP20140551T1 (pl)
IL (1) IL216984A (pl)
MX (1) MX2011013680A (pl)
PL (1) PL2264055T3 (pl)
PT (1) PT2264055E (pl)
RU (1) RU2558259C2 (pl)
SG (1) SG176859A1 (pl)
SI (1) SI2264055T1 (pl)
WO (1) WO2010145820A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109456989B (zh) * 2018-10-31 2022-03-29 陕西慧康生物科技有限责任公司 一种提高毕赤酵母分泌表达的载体的构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2319709C2 (ru) * 2001-07-17 2008-03-20 Рисерч Дивелопмент Фаундейшн Терапевтические агенты, содержащие проапоптозные белки
ITMI20020147A1 (it) * 2002-01-29 2003-07-29 Indena Spa Estrazione purificazione e modificazione di polipeptidi da seme di soia
WO2007147064A2 (en) * 2006-06-14 2007-12-21 Pioneer Hi-Bred International, Inc. Modified soy proteins and methods of use

Also Published As

Publication number Publication date
JP5778138B2 (ja) 2015-09-16
EP2443142A1 (en) 2012-04-25
US8569455B2 (en) 2013-10-29
RU2558259C2 (ru) 2015-07-27
JP2012530090A (ja) 2012-11-29
KR20120027355A (ko) 2012-03-21
CN102753571B (zh) 2015-11-25
KR101689640B1 (ko) 2016-12-26
HRP20140551T1 (hr) 2014-07-18
PT2264055E (pt) 2014-05-07
WO2010145820A1 (en) 2010-12-23
CN102753571A (zh) 2012-10-24
AU2010262061B2 (en) 2016-05-05
MX2011013680A (es) 2012-01-20
CA2765737C (en) 2017-11-21
SG176859A1 (en) 2012-01-30
CL2011003159A1 (es) 2012-04-20
SI2264055T1 (sl) 2014-05-30
RU2011151387A (ru) 2013-07-27
CA2765737A1 (en) 2010-12-23
EP2264055B1 (en) 2014-03-26
BRPI1010686A2 (pt) 2016-03-15
IL216984A0 (en) 2012-02-29
HK1151807A1 (en) 2012-02-10
US20120172316A1 (en) 2012-07-05
DK2264055T3 (da) 2014-04-07
EP2264055A1 (en) 2010-12-22
ES2460898T3 (es) 2014-05-14
AU2010262061A1 (en) 2012-01-19
IL216984A (en) 2017-10-31

Similar Documents

Publication Publication Date Title
IL260117A (en) Use of placental cells to treat diseases, syndromes or conditions of the lungs
WO2011059836A8 (en) T cell receptor-deficient t cell compositions
PL2293685T3 (pl) Koncentraty i izolaty białkowe z nasion oleistych i sposoby ich wytwarzania
PL2498620T3 (pl) Koncentraty i izolaty białkowe i sposoby ich wytwarzania
SG10201408166QA (en) Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion
IL206975A (en) Enzyme n- Acetylgalactosamine-6-purified human recombinant sulfate and its uses
IL215603A0 (en) Human protein scaffold with controlled serum pharmacokinetics, compositions comprising the same and uses thereof
EP2632260A4 (en) LEUCINREICH REPEAT KINASE ENZYME ACTIVITY
IL190732A0 (en) Immunomodulation using placental stem cells
ZA200810412B (en) Placental niche and use thereof to culture stem cells
PL2498619T3 (pl) Koncentraty i izolaty białkowe, i sposoby ich wytwarzania z opiekanej mączki z nasion oleistych
SI1935331T1 (sl) Postopek za pripravo modificiranih elektrod, elektrode pripravljene z omenjenim postopkom in encimatski biosenzorji, ki obsegajo omenjene elektrode
WO2007097993A3 (en) Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor
PL2576768T3 (pl) Oczyszczanie niehodowanych komórek macierzystych galarety Whartona
EP2370093A4 (en) NEUREGULIN AND CARDIAC STEM CELLS
EP4595990A3 (en) Tubular protheses
EP2019860A4 (en) PROTEIN PRODUCTION USING EUKARYOTIC CELL LINES
WO2009058451A3 (en) Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells
PL1945757T3 (pl) Sposób dostarczania komórek progenitorowych mieszków włosowych do skóry
IL204668A0 (en) Use of sulfonyl - substituted 2 - sulfonylaminobenzoic acid n - phenylamides in the treatment of pain
ZA201007259B (en) Kit for collecting blood,preferably peripheral blood,for the production of stem cells
IL215103A0 (en) N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]-ARYL-METHYL]-HETEROBENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE OF SAME
NZ601735A (en) Antibody with binding specificity for Nedd4 protein for reducing influenza infectivity
IL216984A0 (en) Cloning, yeast expression, purification and biological activity of the extension region of the soybean 7s globulin alfa' subunit involved in hep g2 cell cholesterol homeostasis
GB0820397D0 (en) Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases